Wu Chengsheng, Von Schalscha Tami, Sansanwal Diva, Qian Chen, Jiang Qinlin, Shepard Ryan M, Wettersten Hiromi I, McCormack Stephen J, Weis Sara M, Cheresh David A
Department of Pathology, Moores Cancer Center, Sanford Consortium for Regenerative Medicine at the University of California, San Diego, La Jolla, California.
Alpha Beta Therapeutics, Inc., Claremont, California.
Cancer Res Commun. 2025 Jan 1;5(1):195-208. doi: 10.1158/2767-9764.CRC-24-0491.
Simultaneous targeting of two integrins that function as receptors for FN, a protumor ECM protein, can prevent fibroblasts from supporting the malignant behavior of pancreatic cancer cells.
同时靶向两种作为肿瘤细胞外基质蛋白纤连蛋白(FN)受体的整合素,可阻止成纤维细胞支持胰腺癌细胞的恶性行为。